Please wait while the formulary information is being retrieved.
TENIPOSIDE (TENIPOSIDE)
- Acute lymphoid leukemia
50 mg/5 mL intravenous solution
- Infuse 165 mg/m2 over at least 30 minute(s) by intravenous route once
Acute lymphoid leukemia
- Infuse 165 mg/m2 over at least 30 minute(s) by intravenous route once
- Infuse 165 mg/m2 over at least 30 minute(s) by intravenous route on days 1, 4, 8 and 11 of alternating consolidation cycles
- adenovirus vac live type-4 & 7
- adenovirus vaccine live type-4
- adenovirus vaccine live type-7
- BCG vaccine, live (PF)
- flu vac,qval 2013-14 (2-49yrs)
- Flumist 2013-2014
- M-m-r Ii (pf)
- measles,mumps&rubella vacc(PF)
- measles,mumps,rub,varicel(PF)
- natalizumab
- Proquad (pf)
- Rotateq Vaccine
- rotavirus vaccine live, penta
- typhoid vaccine
- Tysabri
- varicella virus vacc live (PF)
- Varivax (pf)
- Vivotif Berna Vaccine
- yellow fever vaccine live (PF)
- Yf-vax (pf)
- Zostavax (pf)
- zoster vaccine live (PF)
Contraindicated
- clozapine
- Clozaril
- deferiprone
- Fazaclo
- Ferriprox
- Versacloz
Severe
Moderate
- None
- Lactating mother
Contraindicated
- Anemia
- Bone marrow depression
- Down's syndrome
- Hemorrhage
- Neutropenic disorder
- Pregnancy
- Severe infection
- Thrombocytopenic disorder
Severe
Moderate
- Disease of liver
- Kidney disease with reduction in GFR
TENIPOSIDE (TENIPOSIDE)
- Acute lymphoid leukemia
- Anemia
- Chest tightness
- Chills
- Drug fever
- Dyspnea
- Hypersensitivity drug reaction
- Hypertension
- Leukopenia
- Neutropenic disorder
- Stomatitis
- Thrombocytopenic disorder
- Urticaria
- Wheezing
- Alopecia
- Diarrhea
- Flushing
- Nausea
- Vomiting
More Frequent
Severe
Less Severe
- Hypotension
- Skin rash
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Bronchospastic pulmonary disease
- CNS depression
- CNS toxicity
- Disease of liver
- Kidney disease with reduction in GFR
- Metabolic acidosis
- Tachycardia
Less Severe
- Acute confusion
- General weakness
- Headache disorder
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Teniposide
- Severity Level:
D
- Additional Notes:
Contraindicated
Teniposide
Potential for serious adverse effects on infant
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Potential for serious adverse effects on infant |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- This medication may cause certain severe blood and bone marrow problems (low red blood cells/white blood cells/platelets). This can affect your body's ability to stop bleeding or fight infection. Tell your doctor right away if you develop easy bleeding/bruising or signs of infection (e.g., fever, chills, persistent sore throat).<br /><br /> This medication can also cause a serious allergic reaction. Your health care professional will monitor you closely during treatment for any signs of a reaction. (See also Side Effects section.)
| Acute lymphoid leukemia | |
| C91.0 | Acute lymphoblastic leukemia [ALl] |
| C91.00 | Acute lymphoblastic leukemia not having achieved remission |
| C91.02 | Acute lymphoblastic leukemia, in relapse |
| 0-9 | A-Z |
|---|---|
| C91.0 | Acute lymphoblastic leukemia [ALl] |
| C91.00 | Acute lymphoblastic leukemia not having achieved remission |
| C91.02 | Acute lymphoblastic leukemia, in relapse |
Formulary Reference Tool